title: Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM).
abstract: Immunostimulating complexes (ISCOMs) are subunit vaccines that are particularly effective in producing immunity against systemic viral infections, but their effectiveness against mucosal infections has received little attention. To study their ability to produce mucosal immune responses in the female reproductive tract, a model ISCOM was prepared containing sheep erythrocyte membrane proteins, and anti-erythrocyte IgA and IgG titres in mouse vaginal washings were measured after immunization at parenteral or local mucosal sites. The ISCOM was prepared by a modified procedure that resulted in incorporation of 10-15% of initial membrane protein compared with 1-5% previously reported. Electrophoretic analysis demonstrated that four out of five erythrocyte membrane proteins were incorporated into the ISCOM, and electron microscopic observations indicated that the ISCOM had a cage-like structure with a diameter of 40 nm, similar to previous ISCOMs. Immunization in the pelvic presacral space (p.s.-p.s.) stimulated significantly higher anti-erythrocyte IgA titres in vaginal fluid than were produced by intraperitoneal (i.p.-i.p.), subcutaneous (s.c.-s.c.), intravaginal (i.vag.-i.vag.), or i.p.-i.vag. immunizations with the same vaccine. Specific IgG titres were less dependent on the route of immunization, with p.s.-p.s., i.p.-i.p. and s.c.-s.c. administration all giving similar high titres while i.p.-i.vag. treatment induced lower titres. These observations using a model ISCOM indicate that mucosal immune responses against membrane proteins were elicited in the female reproductive tract, and that non-mucosal immunization in the pelvis was a more effective route of administration than local application of the ISCOM to the vaginal mucosa.
authors.affiliation: Department of Anatomy, School of Medicine, Southern Illinois University, Carbondale 62901.
authors.forename: M A
authors.initials: MA
authors.lastname: Thapar
authors.forename: E L
authors.initials: EL
authors.lastname: Parr
authors.forename: J J
authors.initials: JJ
authors.lastname: Bozzola
authors.forename: M B
authors.initials: MB
authors.lastname: Parr
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000917:Antibody Formation; D004910:Erythrocyte Membrane / Q000276:immunology; D005260:Female; D007267:Injections; D051379:Mice; D009092:Mucous Membrane / Q000276:immunology; D062605:Quillaja Saponins; D012503:Saponins; D012756:Sheep / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage*; D014621:Vagina / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D062605:Quillaja Saponins; D012503:Saponins; D014614:Vaccines, Synthetic; C046386:Quil A